Meet with us at VIVE 2024!

Add Your Heading Text Here

RPM Dashboard
Article

How To Build Well-Rounded Team For Your RPM Program

6 min read

Remote patient monitoring (RPM) programs are beneficial for both patients and medical practices. But an RPM initiative’s success depends on the people behind the program. In this article, we look at why RPM programs have become so popular and the roles and responsibilities of an RPM team. To close, we share five easy-to-implement strategies for creating a strong RPM program.

Why RPM is Growing

The adoption rate of remote patient monitoring has grown dramatically in recent years. According to Insider Intelligence, 30 million patients in the U.S. will be using at least one RPM device by 2024. Here are six significant catalysts driving the rapid adoption rates of RPM technology.

COVID-19 pandemic

With much of the country brought to a standstill, the COVID-19 pandemic rapidly accelerated already emerging trends in virtual care. More insurers began covering telehealth services, dramatically increasing adoption. Remote patient monitoring devices allow medical professionals to monitor their patients’ key health metrics without having them come into the office, making RPM a significant value-add to a practice’s telehealth services.

Increase in chronic conditions such as diabetes

As the rates of long-term conditions such as heart disease, diabetes and obesity continue to rise in the U.S., remote patient monitoring devices empower patients and providers. RPM devices actively monitor key health metrics like blood pressure and weight, and the devices can be set to send data to the patient’s physician. These capabilities give patients and providers the longitudinal information they need to make changes that improve health outcomes.

Convenience

Work, family, and other obligations can quickly crowd out a schedule. RPM devices make it easy for patients to quickly take vital measures like blood pressure and weight. These measures can be automatically transmitted to the healthcare provider via cellular, WiFi, or Bluetooth connection and are instantly accessible to the patient via an easy-to-use mobile app.

Higher levels of patient care

Remote patient monitoring devices enable more frequent health measurements. With access to near real-time health data and the ability to observe historical trends in this data, healthcare providers can make better-informed care recommendations and treatment decisions.

Expand care to more diverse patient groups

For many patients, work schedules, child care or eldercare obligations, distance, or lack of reliable transportation are formidable barriers to receiving care. Low income, elderly, and patients living in underserved or rural areas can receive outsized benefits from participating in a remote patient monitoring program since it can reduce the number of office visits needed.

New revenue streams for healthcare practices

Because many RPM services are billable, RPM programs are a source of additional revenue, allowing practices to tap into new revenue streams that can improve overall profitability.

Key RPM Program Team Members

Building a strong, sustainable remote patient monitoring program requires teamwork and a shared vision. The following team members form the core of a successful remote patient monitoring program.

Top-level management

Beginning any new initiative requires the strong support and buy-in of top-level management. Healthcare executives play a key role in securing funding and staff resources, as well as providing the long-range vision needed to set a new remote patient monitoring program on a secure footing.

Physicians

Physicians can reap substantial benefits from using remote patient monitoring technology with their patients. With a wealth of patient health data, providers can make better-informed treatment decisions. Educating providers on benefits, obtaining their buy-in, and offering focused training on how to access remote patient monitoring data are essential for success.

IT support

The support of the IT department is crucial for ensuring that the technical aspects of creating and running a remote patient monitoring program are executed. Some remote patient monitoring providers like Withings Health Solutions handle most of the IT-related setup, freeing your tech support staff to focus their efforts elsewhere.

Patient navigator

Patient navigators help patients access and use their devices, troubleshooting issues that prevent them from making the most out of participating in a remote patient monitoring program. These staff members are one of the most critical components, providing front-line support and encouragement to patients as they become familiar with their new devices. Some connected devices, like those Withings Health Solutions offers, are intuitive and easy to use, making the jobs of patient navigators much simpler.

Digital health staff trainer

Staff trainers are responsible for training physicians and other practice staff involved in the program’s administration. Key topics for training include how to access and interpret patient data via the physician data dashboard and the correct use of RPM billing codes for payer reimbursement.

Medical billing representative

Medicare and many private insurers will pay for certain patient services provided via remote patient monitoring programs. Remote patient monitoring programs have their own unique set of billing codes, and the medical billing representative will ensure that the correct codes are being used on all claims filed.

Program coordinator

The remote patient monitoring program coordinator is responsible for overseeing the overall health of the program, managing the interactions between team members, troubleshooting patient and provider issues, and assessing program success based on predefined goals.

5 Tips for creating a stronger, more sustainable RPM program

Remote patient monitoring programs require careful planning and diligent follow-through during implementation in order for patients, providers, and practices to realize the full range of potential benefits this technology has to offer. These five tips can help you and the patients you serve get the most out of remote patient monitoring.

Clarify RPM program goals

First, defining what expect your remote patient monitoring program to accomplish. Clear goals not only sharpen the team’s focus but provide an objective set of criteria with which to measure program success.

Quantify expected cost/revenue metrics

Remote patient monitoring programs must be financially sustainable. Quantifying anticipated program costs and revenue enables teams to determine expected ROI. These metrics can justify the time and capital investments required for a successful launch. RPM can reduce overall costs, as it enables physicians to take preventative measurements before a condition becomes severe.

Engage the support of internal stakeholders

Top-level management, providers, and office support staff all have an important role to play in the success of a remote patient monitoring program. Gaining their support upfront is critical. If stakeholders aren’t engaged, program performance will suffer.

Invest the resources needed for program success

Engaging key personnel is an essential ingredient for ensuring long-term success, so additional staff members may need to be hired. Dedicating a program manager to oversee the effort ensures program continuity and provides a single point of contact for other team members when issues arise. Patient navigators are front-line workers who ensure patients are familiar with their devices and responsible for removing barriers to consistent use. Fortunately, the cost of hiring may be offset by billing and reimbursement for RPM services and/or lowered costs if the practice is part of a value-based care system.

Select a high-quality RPM provider to partner with

Some remote patient monitoring providers are better than others. Invest the time to research each potential partner, ensuring they offer higher quality, patient-friendly devices that are easy to use, an intuitive patient-facing health data app, and a streamlined practice-level program dashboard. The ideal RPM provider will have substantial industry experience and a track record of providing superior customer service.

Withings Health Solutions and Withings RPM: an All-in-One RPM Solution

Withings Health Solutions is committed to transforming the lives of healthcare consumers and professionals through beautifully simple monitoring solutions. Here’s how we make implementing a successful remote patient monitoring program seamlessly simple.

Effortless onboarding — Onboard your patients directly from the platform in 3 minutes or less.

Time-efficient monitoring — You’ll appreciate the one-click patient triaging through standard alerts and measurement plans.

Automatic time logging — Time spent taking care of your patients (when reviewing their charts or calling them) is automatically documented to streamline claim creation while maximizing revenue. Time spent outside the platform can easily be manually logged as well.

Optimized billing — In real-time, assess how much a CPT code can be billed and identify which patients to focus on. At the end of the month, generate comprehensive reports in one click to create claims including the CMS1500 information required for the billing.

Program dashboard — Manage your practice at a glance. A comprehensive dashboard allows care teams to view patients’ status, take action based on patient vitals and treatment plans, and easily bill for care rendered.

Patient application — The patient application allows the patient to visualize their measurements history, progress, and measurements objective. Login is simple and doesn’t require any signup or app download.

EHR integration — Withings RPM integrates with virtually every EHR to improve each step of the clinical workflow from device ordering to billing.

Learn more about Withings Health Solutions for remote patient monitoring.

Don’t miss out,  subscribe to get the latest content updates.  

Related Content

WP_Query Object ( [query] => Array ( [post_type] => post [post_status] => publish [orderby] => date [order] => DESC [ignore_sticky_posts] => 1 [post__not_in] => Array ( [0] => 379 ) [cat] => 18 [posts_per_page] => 3 ) [query_vars] => Array ( [post_type] => post [post_status] => publish [orderby] => date [order] => DESC [ignore_sticky_posts] => 1 [post__not_in] => Array ( [0] => 379 ) [cat] => 18 [posts_per_page] => 3 [error] => [m] => [p] => 0 [post_parent] => [subpost] => [subpost_id] => [attachment] => [attachment_id] => 0 [name] => [pagename] => [page_id] => 0 [second] => [minute] => [hour] => [day] => 0 [monthnum] => 0 [year] => 0 [w] => 0 [category_name] => articles [tag] => [tag_id] => [author] => [author_name] => [feed] => [tb] => [paged] => 0 [meta_key] => [meta_value] => [preview] => [s] => [sentence] => [title] => [fields] => [menu_order] => => [category__in] => Array ( ) [category__not_in] => Array ( ) [category__and] => Array ( ) [post__in] => Array ( ) [post_name__in] => Array ( ) [tag__in] => Array ( ) [tag__not_in] => Array ( ) [tag__and] => Array ( ) [tag_slug__in] => Array ( ) [tag_slug__and] => Array ( ) [post_parent__in] => Array ( ) [post_parent__not_in] => Array ( ) [author__in] => Array ( ) [author__not_in] => Array ( ) [search_columns] => Array ( ) [suppress_filters] => [cache_results] => 1 [update_post_term_cache] => 1 [update_menu_item_cache] => [lazy_load_term_meta] => 1 [update_post_meta_cache] => 1 [nopaging] => [comments_per_page] => 50 [no_found_rows] => ) [tax_query] => WP_Tax_Query Object ( [queries] => Array ( [0] => Array ( [taxonomy] => category [terms] => Array ( [0] => 18 ) [field] => term_id [operator] => IN [include_children] => 1 ) ) [relation] => AND [table_aliases:protected] => Array ( [0] => wp_term_relationships ) [queried_terms] => Array ( [category] => Array ( [terms] => Array ( [0] => 18 ) [field] => term_id ) ) [primary_table] => wp_posts [primary_id_column] => ID ) [meta_query] => WP_Meta_Query Object ( [queries] => Array ( ) [relation] => [meta_table] => [meta_id_column] => [primary_table] => [primary_id_column] => [table_aliases:protected] => Array ( ) [clauses:protected] => Array ( ) [has_or_relation:protected] => ) [date_query] => [request] => SELECT SQL_CALC_FOUND_ROWS wp_posts.ID FROM wp_posts LEFT JOIN wp_term_relationships ON (wp_posts.ID = wp_term_relationships.object_id) WHERE 1=1 AND wp_posts.ID NOT IN (379) AND ( wp_term_relationships.term_taxonomy_id IN (18) ) AND wp_posts.post_type = 'post' AND ((wp_posts.post_status = 'publish')) GROUP BY wp_posts.ID ORDER BY wp_posts.post_date DESC LIMIT 0, 3 [posts] => Array ( [0] => WP_Post Object ( [ID] => 1188 [post_author] => 8 [post_date] => 2024-04-16 08:12:38 [post_date_gmt] => 2024-04-16 08:12:38 [post_content] =>

Calls have been growing louder to more effectively address the related problems of diabetes-related foot ulcers (DFUs) and amputations, two of the most serious consequences of diabetes-related peripheral neuropathy (DPN). Health associations like the American Diabetes Association® (ADA), patient advocacy groups, patients, and providers all see the need to improve the detection of DPN, earlier intervention, and more effective treatments to combat an amputation problem that disproportionately impacts communities of color and lower economic status.

 

Unfortunately, there is not a large body of research related to the question of simple compliance with the ADA’s standard of an annual foot exam for people with diabetes. However, a study published in Clinical Nursing Research journal in 2017 indicated only 16% of patient charts reviewed in a specialty clinic met the ADA’s standard for an annual foot exam. Clinicians regularly report seeing patients who present with serious DFUs who have never had a proper foot examination.

 

With the goal of promoting patient education on diabetes-related foot health, earlier detection of neuropathy, and regular diabetes-related foot exams, Withings has partnered with the ADA’s Project Power to put smart scales in the homes of approximately 2,305 participants in 849 cities with particularly high-risk and vulnerable communities. Project Power’s goal is to reduce diabetes risk factors and improve diabetes health literacy, self-care behaviors, and glycemic management. The program is conducted with a combination of in-person and remote sessions that focus on topics such as nutrition, exercise, emotional health, heart health, glucose monitoring, and foot health.

 

Sherry Hill, program director for Project Power, commented, “We are excited to be working with Withings to bring the Project Power participant experience to the next level. By bringing smart scale technology into our participants’ homes, we hope to provide personalized solutions to achieve healthier living goals to reduce the risk for type 2 diabetes and help prevent or delay its complications.”

 

For Withings, Project Power is one of the many examples of how its sophisticated health technology is being used to better connect patients and their health coaches with appropriate care from a clinician. By flagging potential issues earlier and setting up regular monitoring, patient health outcomes can be improved. Through early interventions, lifestyle changes have a better chance of slowing complications.


Learn more about Project Power.

Interested in partnering with us?

Contact Us [post_title] => The ADA and Withings Join Forces to Reduce Diabetes Risk and Complications [post_excerpt] => Peer-reviewed studies have shown that only a fraction of people with diabetes comply with the American Diabetes Association (ADA) standard of annual foot exams. The ADA is now using Withings smart scales in its signature Project Power program to promote regular foot exams and better foot health for people at high-risk for diabetes [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => ada-and-withings-diabetic-foot-health [to_ping] => [pinged] => [post_modified] => 2024-04-16 08:12:39 [post_modified_gmt] => 2024-04-16 08:12:39 [post_content_filtered] => [post_parent] => 0 [guid] => https://withingshealthsolutions.com/?p=1188 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [1] => WP_Post Object ( [ID] => 1183 [post_author] => 1 [post_date] => 2024-04-16 08:11:42 [post_date_gmt] => 2024-04-16 08:11:42 [post_content] =>

In an interview with Harvard Medical School’s Harvard Health, Dr. Khosro Farhad, a neuropathy expert at Harvard-affiliated Massachusetts General Hospital, noted that small-fiber neuropathy is generally underdiagnosed because routine neurological exams and tests cannot accurately discriminate between large-fiber and small-fiber neuropathy. 

 

In a literature review of diabetic peripheral neuropathy diagnostic and screening technologies in the Journal of Diabetes Science and Technology, Kelley Newlin Lew et al pointed out that the body of research backs up the assertion that distal symmetrical peripheral neuropathy  - including both small- and large-fiber neuropathy - is underdiagnosed in primary care (1).

 

The article points out: 

Small- and large-nerve fiber DSPN (distal symmetrical peripheral neuropathy) may present exclusively or together while each subtype may increase risk for foot ulceration due to reduced sensory function, and thereby heightened risk for lower extremity amputations. According to the ADA, the clinical history and physical examination often are sufficient for diagnosis of DSPN. Yet, up to 50% of individuals with DSPN may be asymptomatic.

 

Small-fiber DSPN typically precedes large-fiber neuropathy. Small-fiber DSPN impairs functional integrity of the small thinly myelinated Aδ and unmyelinated C fibers. These small, peripheral nerve fibers prominently convey pain to the central nervous system. In DSPN, they may stimulate profound pain. Small-fiber DSPN may also adversely affect local autonomic (eg, decreased sweating, dry skin, impaired vasomotion) and thermoreceptor (cold, warm sensations) functions.

 

Often, pain and other symptoms and signs first manifest in the feet and progress proximally to the lower extremities and, in some cases, to the hands with a stocking and glove pattern. However, some with small-fiber DSPN may not experience pain. A proportion of patients with small-fiber neuropathy may present with little evidence of the disease, which may delay DSPN diagnosis.

 

 

The primary care practitioner’s toolbox for diagnosing diabetic peripheral neuropathy has been very limited to date, with tools such as temperature and pin-prick sensation, 128-Hz tuning fork, and 10-g monofilament that are neither quantifiable nor reproducible and are prone to human error. Further, since the ADA Standards of Care only call for annual foot exams for people with a diagnosis of diabetes, a large number of patients with pre-diabetes accompanied by the onset of small fiber neuropathy, miss the chance for an early diagnosis (2,3).

 

Withings is focused intently on this deficit in detection technologies in primary care and other frontline environments. As Newlin Lew points out in the Journal of Diabetes Science and Technology article, the Sudoscan® Electrochemical Skin Conductance (ESC) technology being used in our Body Pro 2 device, and that has been used in clinical settings for nearly a decade, could play an important role in improving detection and monitoring:   

 

When considered with respect to past and more recent research, Sudoscan has substantial evidence revealing it may potentially identify early DSPN (although this is not its main use) and monitor DSPN progression over time. Sudoscan also has adequate reproducibility and repeatability. Sudoscan is approved by the FDA and may be reimbursed through proper billing. Sudoscan is thus a POCD [point of care device] worthy of clinical adoption to detect and monitor DSPN in clinical settings.

 

  1. Newlin Lew K, Arnold T, Cantelmo C, Jacque F, Posada-Quintero H, Luthra P, Chon KH. Diabetes Distal Peripheral Neuropathy: Subtypes and Diagnostic and Screening Technologies. Journal of Diabetes Science and Technology. 2022 Mar;16(2):295-320. doi: 10.1177/19322968211035375. Epub 2022 Jan 7. PMID: 34994241; PMCID: PMC8861801. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861801/
  2. Williams SM, Eleftheriadou A, Alam U, Cuthbertson DJ, Wilding JPH. Cardiac Autonomic Neuropathy in Obesity, the Metabolic Syndrome and Prediabetes: A Narrative Review. Diabetes Ther. 2019 Dec;10(6):1995-2021. doi: 10.1007/s13300-019-00693-0. Epub 2019 Sep 24. Erratum in: Diabetes Ther. 2019 Oct 4;: PMID: 31552598; PMCID: PMC6848658. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848658/
  3.  Burgess J, Frank B, Marshall A, Khalil RS, Ponirakis G, Petropoulos IN, Cuthbertson DJ, Malik RA, Alam U. Early Detection of Diabetic Peripheral Neuropathy: A Focus on Small Nerve Fibres. Diagnostics (Basel). 2021 Jan 24;11(2):165. doi: 10.3390/diagnostics11020165. PMID: 33498918; PMCID: PMC7911433. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911433/

Interested in partnering with us?

Contact Us [post_title] => Small Fiber Neuropathy - The Under-Diagnosed Peripheral Neuropathy [post_excerpt] => In an interview with Harvard Medical School’s Harvard Health, Dr. Khosro Farhad, a neuropathy expert at Harvard-affiliated Massachusetts General Hospital, noted that small-fiber neuropathy is generally underdiagnosed because routine neurological exams and tests cannot accurately discriminate between large-fiber and small-fiber neuropathy. [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => small-fiber-neuropathy-the-under-diagnosed-peripheral-neuropathy [to_ping] => [pinged] => [post_modified] => 2024-04-16 08:17:26 [post_modified_gmt] => 2024-04-16 08:17:26 [post_content_filtered] => [post_parent] => 0 [guid] => https://withingshealthsolutions.com/?p=1183 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [2] => WP_Post Object ( [ID] => 1184 [post_author] => 1 [post_date] => 2024-04-16 08:09:33 [post_date_gmt] => 2024-04-16 08:09:33 [post_content] =>

Electrochemical Skin Conductance (ESC) is a physiological parameter that measures the reactivity of sweat glands and small nerve fibers in the skin to electrical stimuli. Elevated blood sugar levels can harm blood vessels, inhibiting their ability to supply oxygen and essential nutrients to these small nerves, leading to their deterioration. This effect is amplified because the nerve fibers that supply sweat glands are long, thin and unmyelinated, they are easily damaged. When the sweat glands and small nerve fibers lose functionality, it is a sign of starting peripheral neuropathy.


Diabetic peripheral neuropathy (DPN) affects the majority of patients with diabetes, but it is difficult to diagnose in its early stages because up to half of those affected are asymptomatic (no pain and good feet sensation). These undetected signs and lack of care can lead to Diabetic Foot Ulcer (DFU) and in the worst case to amputation(1). Though late stage DPN cannot be reversed, early detection can help to slow the progression through exercise, HbA1c control, addressing certain vitamin deficiencies, and other lifestyle changes. According to the American Academy of Family Physicians, early detection and treatment of DPN and resulting foot ulcers has the potential to prevent up to 85% of amputations (2,3).


Many studies have demonstrated the link between sudomotor function and the risk for DPN paving the way for the use of the Sudoscan within DPN characterization (4,5,6,7). ESC has now a 15+ year track record of R&D and a body of peer-reviewed research in more than 200 scientific publications. Because of this vast array of clinical evidence,Withings decided to integrate the ESC measurement into its scales leading to the Body Pro 2 device. To measure ESC, patients simply step on the Body Pro 2 scale (8). Electrodes in the scale emit a small painless current to the feet, and the device measures the resulting chloride conductance in the sweat glands. Within 60 seconds, patients and their providers receive their ESC score (and other biomarkers). Low conductance, and thus a low ESC score, indicates sudomotor dysfunction with a known threshold to stratify patients. 


With a persistent DFU and amputation problem impacting millions of people with diabetes, it is clear that current clinical methods and patient compliance are insufficient to markedly reduce incidences. Even for patients who have their annual foot exam, the conventional monofilament test results in a misdiagnosis nearly half the time (9). Skin biopsies are conclusive, but invasive, painful, and especially problematic for patients who have a high risk of infection and whose wounds heal slowly. By contrast, our ESC technology provides a rapid, operator-independent, and reproducible method that can replace monofilament and balance the drawbacks of invasive biopsy.


While preventing DFUs is a complex problem requiring multi-faceted solutions, we are already working with leading providers in the U.S., Europe and Asia to enable easier and more reliable diagnosis and monitoring of DPN using the ESC technology in Body Pro 2. Importantly, we believe that the quantifiable, reproducible, rapid and non-invasive methodology has far more potential for scaling in proportion to the size of the DFU problem, and can better serve the requirements of a highly diverse patient population. 

  1.  Armstrong, D. G., Tan, T.-W., Boulton, A. J. M. & Bus, S. A. Diabetic Foot Ulcers: A Review. JAMA 330, 62–75 (2023).  https://jamanetwork.com/journals/jama/article-abstract/2806655
  2.  Hunt, D. Diabetes: Foot Ulcers and Amputations. Am. Fam. Physician 80, 789–790 (2009).  https://www.aafp.org/pubs/afp/issues/2009/1015/p789.html
  3.  Esquenazi, A., Kwasniewski, M. Lower Limb Amputations: Epidemiology and Assessment. PM&R KnowledgeNow (2017). https://now.aapmr.org/lower-limb-amputations-epidemiology-and-assessment/
  4.  Galiero, R. et al. Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options. Int. J. Mol. Sci. 24, 3554 (2023). https://doi.org/10.3390/ijms24043554
  5.  Casellini, C. M., Parson, H. K., Richardson, M. S., Nevoret, M. L. & Vinik, A. I. Sudoscan, a noninvasive tool for detecting diabetic small fiber neuropathy and autonomic dysfunction. Diabetes Technol. Ther. 15, 948–953 (2013). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817891/
  6.  Vinik, A. I., Nevoret, M.-L. & Casellini, C. The New Age of Sudomotor Function Testing: A Sensitive and Specific Biomarker for Diagnosis, Estimation of Severity, Monitoring Progression, and Regression in Response to Intervention. Front. Endocrinol. 6, 94 (2015). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4463960/
  7. Novak, P. Electrochemical skin conductance: a systematic review. Clin. Auton. Res. Off. J. Clin. Auton. Res. Soc. 29, 17–29 (2019). https://doi.org/10.1007/s10286-017-0467-x
  8.  Riveline, J.-P. et al. Validation of the Body Scan®, a new device to detect small fiber neuropathy by assessment of the sudomotor function: agreement with the Sudoscan®. Front. Neurol. 14, (2023). https://doi.org/10.3389/fneur.2023.1256984
  9.  Dube, S. et al. Effectiveness of Semmes Weinstein 10 gm monofilament in diabetic peripheral neuropathy taking nerve conduction and autonomic function study as reference tests. J. Fam. Med. Prim. Care 11, 6204–6208 (2022). https://doi.org/10.4103/jfmpc.jfmpc_195_22

Interested in partnering with us?

Contact Us [post_title] => Understanding our ESC Technology for Detecting and Monitoring DPN [post_excerpt] => Electrochemical Skin Conductance (ESC) is a physiological parameter that measures the reactivity of sweat glands and small nerve fibers in the skin to electrical stimuli. Elevated blood sugar levels can harm blood vessels, inhibiting their ability to supply oxygen and essential nutrients to these small nerves, leading to their deterioration. This effect is amplified because the nerve fibers that supply sweat glands are long, thin and unmyelinated, they are easily damaged. When the sweat glands and small nerve fibers lose functionality, it is a sign of starting peripheral neuropathy. [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => understanding-our-esc-technology-for-detecting-and-monitoring-dpn [to_ping] => [pinged] => [post_modified] => 2024-04-16 08:15:45 [post_modified_gmt] => 2024-04-16 08:15:45 [post_content_filtered] => [post_parent] => 0 [guid] => https://withingshealthsolutions.com/?p=1184 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) ) [post_count] => 3 [current_post] => -1 [before_loop] => 1 [in_the_loop] => [post] => WP_Post Object ( [ID] => 1188 [post_author] => 8 [post_date] => 2024-04-16 08:12:38 [post_date_gmt] => 2024-04-16 08:12:38 [post_content] =>

Calls have been growing louder to more effectively address the related problems of diabetes-related foot ulcers (DFUs) and amputations, two of the most serious consequences of diabetes-related peripheral neuropathy (DPN). Health associations like the American Diabetes Association® (ADA), patient advocacy groups, patients, and providers all see the need to improve the detection of DPN, earlier intervention, and more effective treatments to combat an amputation problem that disproportionately impacts communities of color and lower economic status.

 

Unfortunately, there is not a large body of research related to the question of simple compliance with the ADA’s standard of an annual foot exam for people with diabetes. However, a study published in Clinical Nursing Research journal in 2017 indicated only 16% of patient charts reviewed in a specialty clinic met the ADA’s standard for an annual foot exam. Clinicians regularly report seeing patients who present with serious DFUs who have never had a proper foot examination.

 

With the goal of promoting patient education on diabetes-related foot health, earlier detection of neuropathy, and regular diabetes-related foot exams, Withings has partnered with the ADA’s Project Power to put smart scales in the homes of approximately 2,305 participants in 849 cities with particularly high-risk and vulnerable communities. Project Power’s goal is to reduce diabetes risk factors and improve diabetes health literacy, self-care behaviors, and glycemic management. The program is conducted with a combination of in-person and remote sessions that focus on topics such as nutrition, exercise, emotional health, heart health, glucose monitoring, and foot health.

 

Sherry Hill, program director for Project Power, commented, “We are excited to be working with Withings to bring the Project Power participant experience to the next level. By bringing smart scale technology into our participants’ homes, we hope to provide personalized solutions to achieve healthier living goals to reduce the risk for type 2 diabetes and help prevent or delay its complications.”

 

For Withings, Project Power is one of the many examples of how its sophisticated health technology is being used to better connect patients and their health coaches with appropriate care from a clinician. By flagging potential issues earlier and setting up regular monitoring, patient health outcomes can be improved. Through early interventions, lifestyle changes have a better chance of slowing complications.


Learn more about Project Power.

Interested in partnering with us?

Contact Us [post_title] => The ADA and Withings Join Forces to Reduce Diabetes Risk and Complications [post_excerpt] => Peer-reviewed studies have shown that only a fraction of people with diabetes comply with the American Diabetes Association (ADA) standard of annual foot exams. The ADA is now using Withings smart scales in its signature Project Power program to promote regular foot exams and better foot health for people at high-risk for diabetes [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => ada-and-withings-diabetic-foot-health [to_ping] => [pinged] => [post_modified] => 2024-04-16 08:12:39 [post_modified_gmt] => 2024-04-16 08:12:39 [post_content_filtered] => [post_parent] => 0 [guid] => https://withingshealthsolutions.com/?p=1188 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [comment_count] => 0 [current_comment] => -1 [found_posts] => 22 [max_num_pages] => 8 [max_num_comment_pages] => 0 [is_single] => [is_preview] => [is_page] => [is_archive] => 1 [is_date] => [is_year] => [is_month] => [is_day] => [is_time] => [is_author] => [is_category] => 1 [is_tag] => [is_tax] => [is_search] => [is_feed] => [is_comment_feed] => [is_trackback] => [is_home] => [is_privacy_policy] => [is_404] => [is_embed] => [is_paged] => [is_admin] => [is_attachment] => [is_singular] => [is_robots] => [is_favicon] => [is_posts_page] => [is_post_type_archive] => [query_vars_hash:WP_Query:private] => f1c78d32b4a5ea84695dc67a9274d272 [query_vars_changed:WP_Query:private] => [thumbnails_cached] => [allow_query_attachment_by_filename:protected] => [stopwords:WP_Query:private] => [compat_fields:WP_Query:private] => Array ( [0] => query_vars_hash [1] => query_vars_changed ) [compat_methods:WP_Query:private] => Array ( [0] => init_query_flags [1] => parse_tax_query ) )
Article

The ADA and Withings Join Forces to Reduce Diabetes Risk and Complications

Read More
Article

Small Fiber Neuropathy – The Under-Diagnosed Peripheral Neuropathy

Read More
Article

Understanding our ESC Technology for Detecting and Monitoring DPN

Read More

Interested in partnering with Withings Health Solutions?

Contact Us

References

About withings health solutions
For developers
For researchers
© 2023 Withings All rights reserved. Terms & Conditions Privacy Policy Cookie Policy
Linkedin